• 1
    Greene FL, Page DL, Fleming ID, et al, eds. AJCC Cancer Staging Manual. 6th ed. New York: Springer-Verlag; 2002.
  • 2
    Fleming ID, Cooper JS, Henson DE, et al, eds. AJCC Cancer Staging Manual. 5th ed. Philadelphia, PA: Lippincott-Raven; 1998.
  • 3
    Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, eds. AJCC Cancer Staging Manual. 7th ed. New York: Springer; 2010.
  • 4
    Goldstein NS, Turner JR. Pericolonic tumor deposits in patients with T3N+M0 colon adenocarcinomas: markers of reduced disease free survival and intra-abdominal metastases and their implications for TNM classification. Cancer. 2000; 88: 2228-2238.
  • 5
    Harrison JC, Dean PJ, el-Zeky F, Vander Zwaag R. Impact of the Crohn's-like lymphoid reaction on staging of right-sided colon cancer: results of multivariate analysis. Hum Pathol. 1995; 26: 31-38.
  • 6
    Nagtegaal ID, Quirke P. Colorectal tumour deposits in the mesorectum and pericolon; a critical review. Histopathology. 2007; 51: 141-149.
  • 7
    Wunsch K, Muller J, Jahnig H, Herrmann RA, Arnholdt HM, Markl B. Shape is not associated with the origin of pericolonic tumor deposits. Am J Clin Pathol. 2010; 133: 388-394.
  • 8
    Quirke P, Morris E. Reporting colorectal cancer. Histopathology. 2007; 50: 103-112.
  • 9
    Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis. 1997; 12: 19-23.
  • 10
    Allen DC, Fon LJ, McAleer JJ, Irwin ST. Pathology of rectal adenocarcinoma following preoperative adjuvant radiotherapy and chemotherapy. Ulster Med J. 1999; 68: 17-21.
  • 11
    Chau I, Brown G, Cunningham D, et al. Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer. J Clin Oncol. 2006; 24: 668-674.
  • 12
    Stein DE, Mahmoud NN, Anne PR, et al. Longer time interval between completion of neoadjuvant chemoradiation and surgical resection does not improve downstaging of rectal carcinoma. Dis Colon Rectum. 2003; 46: 448-453.
  • 13
    Vuong T, Belliveau PJ, Michel RP, et al. Conformal preoperative endorectal brachytherapy treatment for locally advanced rectal cancer: early results of a phase I/II study. Dis Colon Rectum. 2002; 45: 1486-1493.
  • 14
    Hamilton S, Aaltonen L. WHO Classification of Tumours. Pathology and Genetics. Lyon, France: IARC Press; 2000.
  • 15
    Puppa G, Maisonneuve P, Sonzogni A, et al. Pathological assessment of pericolonic tumor deposits in advanced colonic carcinoma: relevance to prognosis and tumor staging. Mod Pathol. 2007; 20: 843-855.
  • 16
    Ueno H, Mochizuki H. Clinical significance of extrabowel skipped cancer infiltration in rectal cancer. Surg Today. 1997; 27: 617-622.
  • 17
    Ueno H, Mochizuki H, Hashiguchi Y, et al. Extramural cancer deposits without nodal structure in colorectal cancer: optimal categorization for prognostic staging. Am J Clin Pathol. 2007; 127: 287-294.
  • 18
    Prabhudesai A, Arif S, Finlayson CJ, Kumar D. Impact of microscopic extranodal tumor deposits on the outcome of patients with rectal cancer. Dis Colon Rectum. 2003; 46: 1531-1537.
  • 19
    Harrison JC, Dean PJ, el-Zeky F, Vander Zwaag R. From Dukes through Jass: pathological prognostic indicators in rectal cancer. Hum Pathol. 1994; 25: 498-505.
  • 20
    Tateishi S, Arima S, Futami K, et al. A clinicopathological investigation of “tumor nodules” in colorectal cancer. Surg Today. 2005; 35: 377-384.
  • 21
    Ueno H, Mochizuki H, Tamakuma S. Prognostic significance of extranodal microscopic foci discontinuous with primary lesion in rectal cancer. Dis Colon Rectum. 1998; 41: 55-61.
  • 22
    Kinoshita H, Watanabe T, Yanagisawa A, Nagawa H, Kato Y, Muto T. Pathological changes of advanced lower-rectal cancer by preoperative radiotherapy. Hepatogastroenterology. 2004; 51: 1362-1366.
  • 23
    Engstrom PF, Arnoletti JP, Benson AB 3rd, et al. NCCN Clinical Practice Guidelines in Oncology: rectal cancer. J Natl Compr Canc Netw. 2009; 7: 838-881.